Introducing Pharmony At this critical time, the PM Society is launching Pharmony, a positive, evidence-led response to counter the negativity and uncertainty that dominates. It’s an initiative that ...

Drug developers integrate AI capabilities as a potentially transformative strategy to combat patent cliff losses.

PharmTech is rebranding to strengthen its commitment to scientists, innovators, and executives in the pharmaceutical industry. The company is introducing a new look, refined content strategy, and ...

Márcio Temtem, Hovione, discusses how to tackle pharma complexity via regional growth in the US, Ireland, and Portugal, using digital tools to accelerate development.

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one of the largest AI partnerships in the pharma industry to date. According to ...

Economic realities: Pharma leadership is often conditioned for the "high-risk, high-reward" physics of pipeline assets. MedTech operates on iterative innovation and service-heavy models. Bridging ...

Pharmaceutical companies, by contrast, are using AI as a lever on an existing, already capital-intensive R&D machine. They ...

The worlds of technology and entrepreneurship are captivated by recent advances in generative AI and large language models (LLMs). But if the future has arrived, as science fiction writer William ...

The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support. For too long, specialty ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million to ...

EssilorLuxottica and Meta have unveiled the second generation of smart glasses, featuring live-streaming and AI applications. Better numbers in EssilorLuxottica's pharma division thanks to Stelles ...